
Senate Panel Takes Aim at Dietary Recommendations in Funding Bill
Advocates for healthy eating say food industry lobbyists are using the political process to interfere in the scientific process.
In what critics say is an effort to defund what they failed to defeat, a Senate Appropriations subcommittee this week is advancing a bill that would thwart the ability of the Obama Administration to implement recommendations from an expert panel that spent a year reviewing scientific evidence to inform the nation’s nutrition policy.
On Tuesday, the panel approved $20.5 billion in discretionary funding, which
Notably, the bill features a rider that requires that the 2015 Dietary Guidelines for Americans, which are being finalized now, be based “solely on nutritional and scientific evidence and not extraneous information.” This language has shown up in another bill, The Hill reports.
In February, the 2015
Food industry lobbyists, and the meat industry in particular, reacted with alarm, and the comment period on the report was extended to accommodate all the feedback. The final guidelines remain under review, which is not necessarily unusual, since the 2010 guidelines were not finalized until January 2011.
Advocates for healthy eating, including some members of DGAC, have sounded the alarm about the behavior of the food industry toward the Congress.
What rankles critics, Nestle wrote, is the fact that DGAC connected agricultural sustainability to health policy. “Some segments of the food industry don’t like what the science so they are using the political system to fight back,” she said.
Among those expressing concern about the DGAC language is US Senator Roy Blunt, a Missouri Republican, according to the
The Post-Dispatch report found that many of the signers of the March letter represent beef-producing states in the Midwest and West, and noted that Blunt’s wife, Abigail, lobbies for Kraft Heinz Co., owner of Oscar Mayer.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.